https://www.selleckchem.com/pr....oducts/aticaprant.ht
1-99.9% at 10 years, and 94.3-96% at 15 years), with high rates of men remaining within the protocols (23-39% at 10 years). This article is a call for focusing further research on development and recommending a precise and standardized, evidence-based protocol for AS in LR-CLPC. This article is a call for focusing further research on development and recommending a precise and standardized, evidence-based protocol for AS in LR-CLPC. Various breast cancer (BC) treatments, such as chemotherapy and targeted therapies, increase cardiotoxi
Like
Comment
Share
